• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睾丸绒毛膜癌中频繁的 EGFR 表达/EGFR 扩增和缺乏激活突变。

Frequent EGFR expression/EGFR amplification and lack of activating mutation in testicular choriocarcinoma.

机构信息

Department of Basic Pathology, National Defense Medical College, Saitama, Japan.

Department of Laboratory Medicine, National Defense Medical College, Saitama, Japan.

出版信息

Pathol Int. 2020 May;70(5):262-269. doi: 10.1111/pin.12905. Epub 2020 Jan 29.

DOI:10.1111/pin.12905
PMID:31994813
Abstract

Choriocarcinoma (CC) is the rarest but most aggressive histological component of adult testicular germ cell tumor (TGCT). Although we previously reported a putative role of epidermal growth factor receptor (EGFR) alterations in the progression of CC, little is known about the kinase-activating mutation status of EGFR, which predicts the response to EGFR-tyrosine kinase inhibitors. In this study, we clinicopathologically reviewed a total of 12 cases of mixed TGCTs with CC components. Immunohistochemistry, fluorescence in situ hybridization, and direct sequencing was performed to investigate EGFR expression, EGFR copy number alterations, and functional mutation of EGFR in these CC components, respectively. Four (33%) of 12 cases exhibited predominant CC components (>50%), and all these patients died due to disease within 62 months. Overexpression of EGFR, higher copy number of EGFR, and amplification of EGFR was observed in 12 (100%), 10 (83%), and 9 (75%) of 12 CC components, respectively. None of the cases showed any mutational events in exons 18 to 24, which encode the tyrosine kinase domain of EGFR. These results confirm an important role of EGFR in the tumor aggressiveness of testicular CCs and may suggest its possible innate resistance against conventional anti-EGFR therapies.

摘要

绒癌(CC)是成人睾丸生殖细胞肿瘤(TGCT)中最罕见但侵袭性最强的组织学成分。尽管我们之前报道了表皮生长因子受体(EGFR)改变在 CC 进展中的作用,但对于预测 EGFR 酪氨酸激酶抑制剂反应的 EGFR 激酶激活突变状态知之甚少。在这项研究中,我们对总共 12 例具有 CC 成分的混合 TGCT 进行了临床病理复习。进行了免疫组织化学、荧光原位杂交和直接测序,以分别研究这些 CC 成分中 EGFR 的表达、EGFR 拷贝数改变和 EGFR 的功能突变。在 12 例病例中,有 4 例(33%)以主要 CC 成分为主(>50%),所有这些患者均因疾病在 62 个月内死亡。在 12 例 CC 成分中,EGFR 的过度表达、EGFR 拷贝数的增加和 EGFR 的扩增分别为 12 例(100%)、10 例(83%)和 9 例(75%)。在 18 至 24 外显子编码 EGFR 酪氨酸激酶结构域的情况下,没有任何病例显示出任何突变事件。这些结果证实了 EGFR 在睾丸 CC 肿瘤侵袭性中的重要作用,并可能提示其对传统抗 EGFR 治疗的固有耐药性。

相似文献

1
Frequent EGFR expression/EGFR amplification and lack of activating mutation in testicular choriocarcinoma.睾丸绒毛膜癌中频繁的 EGFR 表达/EGFR 扩增和缺乏激活突变。
Pathol Int. 2020 May;70(5):262-269. doi: 10.1111/pin.12905. Epub 2020 Jan 29.
2
Protein overexpression and gene amplification of epidermal growth factor receptor in adult testicular germ cell tumors: potential role in tumor progression.成年睾丸生殖细胞肿瘤中表皮生长因子受体的蛋白过表达和基因扩增:在肿瘤进展中的潜在作用。
Cancer Sci. 2010 Sep;101(9):1970-6. doi: 10.1111/j.1349-7006.2010.01638.x.
3
Clinicopathologic analysis of choriocarcinoma as a pure or predominant component of germ cell tumor of the testis.精原细胞瘤中绒毛膜癌作为纯或主要成分的临床病理分析。
Am J Surg Pathol. 2014 Jan;38(1):111-8. doi: 10.1097/PAS.0b013e3182a2926e.
4
Epidermal growth factor receptor protein expression and gene amplification in the chemorefractory metastatic embryonal carcinoma.化学难治性转移性胚胎癌中表皮生长因子受体蛋白表达及基因扩增
Mod Pathol. 2009 Jan;22(1):7-12. doi: 10.1038/modpathol.2008.133. Epub 2008 Jul 25.
5
Somatic copy number alterations are associated with EGFR amplification and shortened survival in patients with primary glioblastoma.体细胞拷贝数改变与原发性胶质母细胞瘤患者的 EGFR 扩增和生存时间缩短相关。
Neoplasia. 2020 Jan;22(1):10-21. doi: 10.1016/j.neo.2019.09.001. Epub 2019 Nov 18.
6
Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patients.表皮生长因子受体(EGFR)扩增与敏感性突变同时存在,表明肺腺癌患者接受EGFR酪氨酸激酶抑制剂(EGFR-TKI)治疗可获得更好的生存获益。
Lung Cancer. 2015 Sep;89(3):337-42. doi: 10.1016/j.lungcan.2015.06.008. Epub 2015 Jun 19.
7
Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.克隆性 MET 扩增作为表皮生长因子受体突变型非小细胞肺癌酪氨酸激酶抑制剂耐药的决定因素。
J Clin Oncol. 2019 Apr 10;37(11):876-884. doi: 10.1200/JCO.18.00177. Epub 2019 Jan 24.
8
Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.通过高分辨率熔解扩增子分析检测肺腺癌中表皮生长因子受体和人表皮生长因子受体2激活突变:与基因拷贝数、蛋白表达及激素受体表达的相关性
Hum Pathol. 2006 Jun;37(6):755-63. doi: 10.1016/j.humpath.2006.02.004.
9
Epithelioid sarcoma expresses epidermal growth factor receptor but gene amplification and kinase domain mutations are rare.上皮样肉瘤表达表皮生长因子受体,但基因扩增和激酶结构域突变罕见。
Mod Pathol. 2010 Apr;23(4):574-80. doi: 10.1038/modpathol.2010.2. Epub 2010 Jan 29.
10
[Testicular germ cell tumors: Histopathological and molecular features].[睾丸生殖细胞肿瘤:组织病理学和分子特征]
Bull Cancer. 2019 Apr;106(4):328-341. doi: 10.1016/j.bulcan.2019.02.004. Epub 2019 Mar 21.

引用本文的文献

1
Review of current literature on gestational trophoblastic neoplasia.妊娠滋养细胞肿瘤的文献综述。
J Egypt Natl Canc Inst. 2023 Nov 27;35(1):37. doi: 10.1186/s43046-023-00195-y.
2
Clinically undetected plasmacytoid urothelial carcinoma of the urinary bladder with non-mass-forming metastases in multiple organs: an autopsy case.临床上未被发现的膀胱浆细胞样尿路上皮癌伴多器官非肿块形成性转移:一例尸检病例
J Pathol Transl Med. 2022 Jul;56(4):217-224. doi: 10.4132/jptm.2022.03.15. Epub 2022 May 3.